Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases
Camille M. Syrett, Bam Paneru, Donavon Sandoval-Heglund, Jianle Wang, Sarmistha Banerjee, Vishal Sindhava, Edward M. Behrens, Michael Atchison, Montserrat C. Anguera
Camille M. Syrett, Bam Paneru, Donavon Sandoval-Heglund, Jianle Wang, Sarmistha Banerjee, Vishal Sindhava, Edward M. Behrens, Michael Atchison, Montserrat C. Anguera
View: Text | PDF
Research Article Cell biology

Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases

  • Text
  • PDF
Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder that predominantly affects women and is driven by autoreactive T cell–mediated inflammation. It is known that individuals with multiple X-chromosomes are at increased risk for developing SLE; however, the mechanisms underlying this genetic basis are unclear. Here, we use single cell imaging to determine the epigenetic features of the inactive X (Xi) in developing thymocytes, mature T cell subsets, and T cells from SLE patients and mice. We show that Xist RNA and heterochromatin modifications transiently reappear at the Xi and are missing in mature single positive T cells. Activation of mature T cells restores Xist RNA and heterochromatin marks simultaneously back to the Xi. Notably, X-chromosome inactivation (XCI) maintenance is altered in T cells of SLE patients and late-stage–disease NZB/W F1 female mice, and we show that X-linked genes are abnormally upregulated in SLE patient T cells. SLE T cells also have altered expression of XIST RNA interactome genes, accounting for perturbations of Xi epigenetic features. Thus, abnormal XCI maintenance is a feature of SLE disease, and we propose that Xist RNA localization at the Xi could be an important factor for maintaining dosage compensation of X-linked genes in T cells.

Authors

Camille M. Syrett, Bam Paneru, Donavon Sandoval-Heglund, Jianle Wang, Sarmistha Banerjee, Vishal Sindhava, Edward M. Behrens, Michael Atchison, Montserrat C. Anguera

×

Figure 5

Xist RNA becomes mislocalized from the Xi in T cells from diseased NZB/W F1 mice.

Options: View larger image (or click on image) Download as PowerPoint
Xist RNA becomes mislocalized from the Xi in T cells from diseased NZB/W...
(A) Representative Xist RNA FISH images from resting splenic T cells from late-stage–disease NZB/W F1 mice (determined by proteinuria and serum dsDNA autoantibody levels) and age-matched healthy controls (C57BL/6J, BALB/c). (B) Representative Xist RNA FISH images from in vitro activated (CD3/CD28) splenic T cells from late-stage–disease NZB/W F1 mice and age-matched healthy controls (C57BL/6J, BALB/c). (C) (Left) Quantification of Type III Xist RNA localization patterns in splenic T cells from NZB/W F1 mice from 3 disease stages (predisease, early-stage disease, and late-stage disease) and age-matched controls (n = 4–5 mice/group) for each disease time point. At least 23 nuclei (23–159 nuclei) were counted for each sample; total counts shown in Supplemental Figure 3. (Center and right) Quantification of Type I and Type III Xist RNA localization patterns for in vitro–activated splenic T cells. At least 50 nuclei (50–237 nuclei) were counted for each sample; total counts shown in Supplemental Figure 3. Error bars denote mean ± SD, and statistical significance was determined for each type of Xist RNA localization pattern between all groups using an ordinary 1-way ANOVA (nonparametric tests).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts